INTERNATIONAL PATENT: LYCIA THERAPEUTICS, INC. FILES APPLICATION FOR "CYCLING LYSOSOMAL TARGETING CHIMERAS TARGETING IMMUNOGLOBULIN E (IGE)"

GENEVA, Jan. 20 -- LYCIA THERAPEUTICS, INC. (400 East Jamie Court, Suite 200South San Francisco, California 94080) filed a patent application (PCT/US2025/037013) for "CYCLING LYSOSOMAL TARGETING CHIMERAS TARGETING IMMUNOGLOBULIN E (IGE)" on Jul 09, 2025. With publication no. WO/2026/015664, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KOUGENTAKIS, Christos (c/o Lycia Therapeutics, Inc.400 East Jamie Court, Suite 200South San Francisco, California 94080), LIND, Nicholas (c/o Lycia Therapeutics, Inc.400 East Jamie Court,...